To access this element change to forms mode OFF
Grant Award View - GA279587
Engineering bone marrow-derived stromal cells to express anti-fibrotic...
GA ID:
GA279587
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
27-Oct-2022
Publish Date:
23-Jan-2023
Category:
Medical Research
Grant Term:
1-Jan-2023 to 31-Dec-2026
Value (AUD):
$997,941.82
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 21/22 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Engineering bone marrow-derived stromal cells to express anti-fibrotic cargo as a treatment for chronic kidney disease
Purpose:
Although a number of organs can repair themselves from mild injury, when subjected to persistent injury, they fail to do so. As a result, they undergo organ scarring (fibrosis) and a progressive loss of function. As current therapies fail to effectively stop this scarring process, we aim to engineer human bone marrow-derived stromal cells to express an anti-fibrotic agent (serelaxin), to deliver the therapeutic potential of this combination therapy as a treatment of chronic kidney disease.
GO ID:
GO Title:
Ideas Grants 2022
Internal Reference ID:
2022/GNT2019014
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, NSW, VIC
Postcode:
Multiple
Country:
AUSTRALIA